SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Ida B. Wells — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientIda B. Wells
Date of birth1862-07-16
IdentifiersMRN HR-ET022-SYN-TD; SSN (made up) 000-22-5903
Document date1931-01-20
AuthorCordelia Ashworth-Banks, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-week review of home blood pressure readings, the repeat urine test and the kidney ultrasound, with the nephrology consultation. [S]

History of Present Illness

Mrs. Wells returns two weeks after her first visit with her home blood pressure log and the outside report she obtained: two years ago another clinic measured her creatinine at 1.05 mg/dL and reported an eGFR of 64 as normal. That report used an older equation that raised the estimate for Black patients; recalculated with the race-free CKD-EPI 1926 equation it is 59, already reduced, and no urine albumin test was done then. Her home readings over seven days average 150/88. She stopped naproxen at the first visit and uses acetaminophen for her knees, which works. Her ankles still swell a little by evening and she is still tired in the afternoons. She had her kidney ultrasound this morning and saw Dr. Lindqvist-Moore of nephrology afterwards. She asked to see each calculation and was given copies. [S]

ElementDetail
Home blood pressureAverage 150/88 over seven days
Earlier resultCreatinine 1.05 two years ago, reported with a race-adjusted eGFR of 64; race-free eGFR 59
NaproxenStopped; acetaminophen instead
SymptomsTiredness and evening ankle swelling, unchanged

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired in the afternoons; no fever or weight loss
CardiovascularPositiveMild ankle swelling by evening; no chest pain or breathlessness lying flat
GenitourinaryNegativeNo blood in the urine, foamy urine, or burning
MusculoskeletalPositiveKnee aching, controlled with acetaminophen
IntegumentaryNegativeNo rash or itching

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, one or two tablets up to three times a day as needed for knee aching (no more than 3,000 mg a day), in place of naproxenOne or two tablets up to three times a day as neededOral route1931-01-05activeS
Losartan 50 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eatingOne tablet daily, with sick-day rulesOral route1931-01-20 to 1931-03-03completedS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route1931-01-20activeS
Cholecalciferol (vitamin D3) 25 mcg (1,000 units) oral tablet, one tablet dailyOne tablet dailyOral route1931-01-20activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1931-01-20Body height157cmS
1931-01-20Body weight70kgS
1931-01-20Body mass index (BMI) [Ratio]28.4kg/m2S
1931-01-20Systolic blood pressure154mm[Hg]S
1931-01-20Diastolic blood pressure90mm[Hg]S
1931-01-20Heart rate76/minS
1931-01-20Respiratory rate16/minS
1931-01-20Body temperature36.7CelS
1931-01-20Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1931-01-20Albumin/Creatinine [Mass Ratio] in Urine228mg/gBelow 30 mg/g normal (A1); 30 to 300 moderately increased (A2); above 300 severely increased (A3)HighS

Physical Exam

Vital signs recorded on 1931-01-20; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 154/90 (average of two), pulse 76; weight 70.0 kg
CardiovascularRegular rhythm; no murmur or rub; trace ankle swelling
RespiratoryClear
SkinNo rash

Problems

ProblemClinical statusVerificationCodeProvenance
Tiredness for some months and ankle swelling by evening, with a raised creatinine (1.42 mg/dL, race-free eGFR 40, confirmed at 38 with cystatin C) and albumin in the urine (240 mg/g) found today; cause and chronicity to be establishedresolvedconfirmed R94.4S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks.
Elevated blood pressure at intake (164/94 mmHg, average of two readings), without a diagnosis of hypertension; home readings for one week to confirmresolvedconfirmed R03.0S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks.
Hypertension, stage 2, confirmed by home readings (average 150/88 mmHg), with chronic kidney diseaseactiveconfirmed I12.9S — Synthetic modern diagnosis; no blood pressure from her life is recorded.
Chronic kidney disease G3b A2 (eGFR 38 by creatinine and cystatin C, urine albumin-to-creatinine ratio 240 and 228 mg/g), present at least two years; small, echogenic kidneys without obstruction; most likely hypertensive kidney disease, with APOL1-associated disease possible; 5-year kidney failure risk about 7%activeconfirmed N18.32S — Synthetic modern diagnosis linked to the kidney disease recorded at her death.
Anemia of chronic kidney disease, mild (hemoglobin 11.2 g/dL) with adequate iron stores; a likely part of her tirednessactiveconfirmed D63.1S — Synthetic laboratory finding.
Vitamin D deficiency (25-hydroxyvitamin D 17 ng/mL) with a mildly raised PTH (84 pg/mL); calcium and phosphate normalactiveconfirmed E55.9S — Synthetic laboratory finding, part of the mineral and bone check in kidney disease.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationStandardized office blood pressure (five minutes' rest, validated cuff, average of two readings)Every visitCompleted today154/90
Self-managementHome blood pressure readingsSeven days to confirm; then the week before each visit while medicines changeCompleted todaySeven-day average 150/88 confirms hypertension
LaboratoryUrine albumin-to-creatinine ratioRepeat to confirm; three to six months after a treatment change; then about twice a year at G3b A2Completed today228 mg/g, confirming the intake result of 240 (A2)
LaboratoryCreatinine with cystatin C (eGFRcr-cys)When decisions depend on accuracy, as at diagnosis and referralUp to dateDone at intake: eGFR 40 by creatinine, 38 with cystatin C; both race-free
LaboratoryUrinalysis with microscopyAt diagnosis and with any changeUp to dateIntake sample: 1+ protein, no blood, bland sediment
ImagingKidney ultrasoundOnce, at diagnosis of chronic kidney disease of uncertain causeCompleted todaySmall echogenic kidneys; no obstruction or stones
LaboratoryMonoclonal protein screen and hepatitis B, hepatitis C and HIV testsOnce, for chronic kidney disease of uncertain cause in an older adultUp to dateDrawn at intake: no monoclonal protein, normal free light chain ratio; hepatitis B surface antigen, hepatitis C antibody and HIV negative; not immune to hepatitis B
SurveyKidney failure risk equation, 2- and 5-yearAt diagnosis and yearly at G3 to G5; before referral decisionsCompleted todayAbout 7% at 5 years and 2% at 2 years (eGFR 38, albumin-to-creatinine ratio 240 mg/g, age 68, female)
LaboratoryPotassium, sodium, bicarbonate, urea nitrogen, creatinine and eGFRTwo to four weeks after starting or increasing an ARB or SGLT2 inhibitor; then with each eGFR check (about twice a year at G3b A2)OrderedLosartan started today; check in two weeks
LaboratoryHemoglobinAt least yearly at G3; recheck in three months when mildly lowUp to date11.2 g/dL at intake; iron studies adequate
LaboratoryCalcium, phosphate, intact PTH and 25-hydroxyvitamin DBaseline at G3; then every 6 to 12 months; vitamin D and PTH three months after starting replacementUp to dateAt intake: calcium 9.2, phosphate 3.8 mg/dL; PTH 84 pg/mL; vitamin D 17 ng/mL; vitamin D3 started today
LaboratoryLipid panelOnce at diagnosis; statin for adults 50 or older with eGFR below 60 without routine repeat testingUp to dateLDL 136 mg/dL at intake; atorvastatin 20 mg started today, without a routine repeat
Medication safetyMedication review: NSAIDs, contrast, dose adjustment, sick-day rulesEvery visitCompleted todayNaproxen stopped and acetaminophen used instead; sick-day rules for losartan explained in writing
Self-managementLifestyle: sodium below 2 g a day, activity, plant-rich dietEvery visitCompleted todayDietitian session booked; sodium and protein targets discussed
Medication safetyVaccines for kidney disease (influenza, pneumococcal, hepatitis B, COVID-19)Review yearly; hepatitis B series if not immuneCompleted todayHigh-dose influenza, PCV20 and hepatitis B dose 1 given after she agreed
ReferralNephrologyWhen 5-year kidney failure risk is 3 to 5% or more, eGFR falls quickly, or the cause is unclearCompleted todaySeen by Dr. Lindqvist-Moore today; review in three months

Goal progress:

Immunizations given today: High-dose influenza vaccine, this season; Pneumococcal conjugate vaccine PCV20; Hepatitis B vaccine (HepB-CpG), dose 1 of 2 [S]

Guideline basis: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease (2021); New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race (2021); KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease (2021); Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update (2017); 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, chronic kidney disease, hypertension, anemia and depression monographs (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Potassium and creatinine in two weeks. Kidney education session and dietitian session in the next month. Call for dizziness, swelling of the lips or tongue (call 911), or vomiting or diarrhea that stops her eating and drinking (hold losartan that day). Next scheduled visit 1931-02-03: two weeks after starting losartan: potassium, creatinine and blood pressure, and the decision about dapagliflozin. [S]